Zijtregtop Eline A M, Winterswijk Louise A, Beishuizen Tammo P A, Zwaan Christian M, Nievelstein Rutger A J, Meyer-Wentrup Friederike A G, Beishuizen Auke
Department of Pediatric Hemato-Oncology, Princess Máxima Centre for Pediatric Oncology, Heidelberglaan 25, 3585 CS Utrecht, The Netherlands.
Department of Pediatric Hematology and Oncology, Erasmus Medical Centre-Sophia Children's Hospital, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands.
Cancers (Basel). 2023 Feb 12;15(4):1178. doi: 10.3390/cancers15041178.
While cervical lymphadenopathy is common in children, a decision model for detecting high-grade lymphoma is lacking. Previously reported individual lymphoma-predicting factors and multivariate models were not sufficiently discriminative for clinical application. To develop a diagnostic scoring tool, we collected data from all children with cervical lymphadenopathy referred to our national pediatric oncology center within 30 months ( = 182). Thirty-nine putative lymphoma-predictive factors were investigated. The outcome groups were classical Hodgkin lymphoma (cHL), nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), non-Hodgkin lymphoma (NHL), other malignancies, and a benign group. We integrated the best univariate predicting factors into a multivariate, machine learning model. Logistic regression allocated each variable a weighing factor. The model was tested in a different patient cohort ( = 60). We report a 12-factor diagnostic model with a sensitivity of 95% (95% CI 89-98%) and a specificity of 88% (95% CI 77-94%) for detecting cHL and NHL. Our 12-factor diagnostic scoring model is highly sensitive and specific in detecting high-grade lymphomas in children with cervical lymphadenopathy. It may enable fast referral to a pediatric oncologist in patients with high-grade lymphoma and may reduce the number of referrals and unnecessary invasive procedures in children with benign lymphadenopathy.
虽然颈部淋巴结病在儿童中很常见,但缺乏用于检测高级别淋巴瘤的决策模型。先前报道的个体淋巴瘤预测因素和多变量模型在临床应用中的判别能力不足。为了开发一种诊断评分工具,我们收集了30个月内转诊至我国国家儿科肿瘤中心的所有颈部淋巴结病患儿的数据(n = 182)。研究了39个假定的淋巴瘤预测因素。结局组包括经典型霍奇金淋巴瘤(cHL)、结节性淋巴细胞为主型霍奇金淋巴瘤(NLPHL)、非霍奇金淋巴瘤(NHL)、其他恶性肿瘤和良性组。我们将最佳单变量预测因素整合到一个多变量机器学习模型中。逻辑回归为每个变量分配一个权重因子。该模型在另一组患者(n = 60)中进行了测试。我们报告了一个12因素诊断模型,用于检测cHL和NHL的灵敏度为95%(95%CI 89 - 98%),特异度为88%(95%CI 77 - 94%)。我们的12因素诊断评分模型在检测颈部淋巴结病患儿的高级别淋巴瘤方面具有高度敏感性和特异性。它可能使高级别淋巴瘤患者能够快速转诊至儿科肿瘤学家处,并可能减少良性淋巴结病患儿的转诊次数和不必要的侵入性检查。